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Distortion product otoacoustic emissions (DPOAEs) are part of hearing screening 
measures as well as the comprehensive audiologic test battery in humans. For canines, the 
brainstem auditory evoked response (BAER) test is currently the gold standard for assessing 
hearing sensitivity in canines. This procedure is minimally invasive, time intensive, costly, and 
does not provide frequency specific information when using a click stimulus. This could create 
challenges in accessibility and ability to test canines’ hearing status on a large scale. Distortion 
product otoacoustic emissions can be a quick, beneficial, and noninvasive method for providing 
ear-specific information on cochlear function of a canine. Performing DPOAEs on canines for 
screening and/or diagnostic purposes is a relatively new area of research and there is currently a 
lack of canine-specific testing equipment, settings, protocols, and universally accepted clinical 
normative data and guidelines. The purpose of this research was to determine what stimulus 
frequency ratios would produce the most robust DPOAEs in canines to support future clinical 
use of DPOAEs to aid in evaluation of hearing status in canines. 
Diagnostic DPOAE tests utilizing nine f2/f1 ratios in the range of 1.18-1.28 were 
completed on the right ear of 10 canine subjects with Mutt Muffs® (Safe & Sound Pets, 2021) 
securely covering the test ear. Results from all 10 subjects showed consistent DPOAE responses 
across the different f2/f1 ratios tested. Therefore, it could be concluded that DPOAEs could be 





significantly different DPOAE responses and the pattern across frequencies did not significantly 
change when the f2/f1 ratio changed. Results from the study also showed the typical canine 
DPOAE responses were observed at 2k Hz and above. Lack of DPOAE responses below 2k Hz 
regardless of the noise floor levels, low ambient noise, and level of canine compliance, and 
degree of quietness suggested the typical DPOAE response was best at 2k Hz and above. In 
general, canine DPOAE responses were robust enough that the f2/f1 ratio did not seem to 
significantly impact the overall amplitudes. Due to the lack of a probe specifically designed for 
canine ears, use of Mutt Muffs or a similar device is recommended, although further research is 
necessary to determine if resonance under the Mutt Muffs changed responses before DPOAEs 
could be incorporated into veterinary practices as a method for hearing screenings/diagnostic 
purposes.  If DPOAEs are to be utilized as a clinical screening tool at this time, a f2/f1 ratio of 
1.18-1.22 is recommended. The f2/f1 ratios 1.18 and 1.20 had the most robust responses overall; 
therefore, it would be ideal to use ratios within that range. The ratio 1.22 is typically used for 
DPOAEs in humans and due to the responses also being robust at this f2/f1 ratio, it would be 
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STATEMENT OF THE PROBLEM 
 
Clinical assessment of hearing sensitivity of canines is a relatively new topic of research 
and only a limited amount of research has been conducted on best practices for hearing 
sensitivity measurements, result interpretations, and guidelines. Currently, the brainstem auditory 
evoked response (BAER) test is the only hearing sensitivity assessment accepted by the 
Orthopedic Foundation for Animals (Sims et al., 2017). This procedure is minimally invasive as 
it only requires small needle electrodes to be placed underneath the skin in three to four locations 
on the canine’s head. The BAER test provides ear specific information and testing can be 
performed at multiple intensity levels and/or with different stimulus frequencies for a diagnostic 
evaluation or threshold estimation measure. The time, cost, and use of needle electrodes can 
create challenges in access and ability to test canines’ hearing status on a large scale.  
Otoacoustic emissions (OAEs) can be a beneficial and noninvasive method for providing 
ear-specific information on the hearing status of a canine. Evaluations of OAEs have been 
completed for canines with respect to age, breed, size, gender, level of consciousness, and status 
of hearing sensitivity; however, there is still more to learn about canine OAE responses. For 
diagnostic and screening purposes, it is imperative that universally accepted clinical normative 
data and guidelines be determined. There is no current reference for appropriate settings to 
collect accurate and robust OAEs in canines. There are no guidelines for what constitutes a 
typical or atypical response with respect to OAEs in canines. Additionally, there has been no 





data, OAEs have not been widely accepted as a measure to evaluate hearing status in canines. To 
perform and interpret OAE or BAER tests on canines, veterinarians and/or audiologists need to 
have knowledge of testing parameters and procedures as well as be trained in result interpretation 
for accurate diagnoses. 
There are differences and similarities between canine and human auditory systems. The 
canine cochlea has more turns than a human cochlea (West, 1985); therefore, it could be inferred 
that canine basilar membranes would be longer and have a greater range of audible frequencies 
than humans (Strain, 2012). Prior to using OAEs clinically to aid in diagnosis of hearing status in 
canines, research needs to be conducted to determine testing procedures, equipment 
modifications, and software settings that would produce optimal OAEs in canines. Therefore, the 
purpose of this study was to determine what stimulus frequency ratios produced the most robust 
OAEs in canines to support future clinical use of OAEs to aid in diagnosis of hearing status in 
canines. 
Research Questions 
Q1 When measuring distortion product otoacoustic emissions (DPOAEs) in canines, 
does the amplitude pattern across frequencies for the 2f1-f2 distortion product 
change with changes in the f2/f1 ratio? 
Q2 When measuring distortion product otoacoustic emissions (DPOAEs) in canines, 
do specific f2/f1 ratios produce different overall amplitudes of the 2f1-f2 
emission? 
Hypotheses 
H1 The amplitude patterns across frequencies for the 2f1-f2 distortion product will 
vary with changes in f2/f1 ratio for canine DPOAEs. 













REVIEW OF THE LITERATURE 
The Canine Auditory System 
Canine auditory systems have structural similarities and differences when compared to 
the auditory system of humans. Moving medially, the anatomical configuration of the canine ear 
is similar to the human ear, starting with the pinna and moving to the ear canal, tympanic 
membrane, middle ear, and inner ear. The canine pinna consists of cartilage and can be either 
erect or pendulous (Njaa et al., 2012). Erect pinnae stand up and pendulous pinnae hang down 
the side of the canine’s head. The purpose of the pinna is to be mobile so it can assist in 
localization, collect the sound waves, and transmit them down the canal toward the tympanic 
membrane (Cole, 2009; Njaa et al., 2012). The external canal opening faces dorsolaterally and 
the tragus forms the boundary of the ear canal laterally (Njaa et al., 2012). The antitragus is 
separated from the tragus via the intertragic incisure, which many clinicians use to aid in guiding 
the otoscope into the ear canal to perform otoscopy on the canine (Njaa et al., 2012). The ear 
canal has two portions: the vertical ear canal, which forms from the concha, and the horizontal 
ear canal, which leads to the tympanic membrane. At the point where the vertical canal turns into 
the horizontal canal, there is a ridge, referred to by some using the informal anatomical term 
Noxon’s Ridge, which can make direct access to the tympanic membrane difficult. To properly 
insert the otoscope and the probe, the pinna must be pulled up and back. Canines have hair in the 





membrane. Cerumen, or ear wax, is produced through the sebaceous and ceruminous glands in 
the ear canal.  
The tympanic membrane is a tri-layered semitransparent membrane that separates the 
outer ear from the middle ear. In canines, the tympanic membrane is angled at 45-degrees 
relative to the horizontal ear canal (Njaa et al., 2012). It has a small upper section termed the pars 
flaccida that is usually flat; however, if it is bulging, that is not necessarily abnormal. A bulging 
pars flaccida can be normal but it can sometimes indicate otitis media. The tympanic membrane 
also has a lower section named the pars tensa, which is larger, thinner, tougher, and consists of 
strands that radiate outward (Cole, 2009). The malleus is the most lateral of the middle ear 
ossicles and attaches to the tympanic membrane via the manubrium (head). This causes the 
tympanic membrane to have a concave shape when viewed through an otoscope. The function of 
the tympanic membrane is to vibrate from the sound-generated waves of air pressure and transfer 
the energy from the vibrations to the ossicles in the middle ear. This is a transformation of 
acoustic energy to mechanical energy. 
 The middle ear anatomy of canines is similar to that of humans; however, some 
differences are worth noting. The middle ear is an air-filled cavity with three ossicles (malleus, 
incus, stapes) suspended through it. The middle ear cavity has three sections: the epitympanic 
recess, ventral cavity, and tympanic cavity proper. The epitympanic recess is the small space that 
holds the malleus and incus (Cole, 2009). The tympanic cavity proper is adjacent to the tympanic 
membrane and has an opening that goes to the ventral cavity. The ventral cavity is the largest of 
the three sections (Cole, 2009). The middle ear ossicles function to transfer the energy from 
tympanic membrane to the oval window in the inner ear, transforming the mechanical energy 





the structures of the middle ear also function to overcome the impedance mismatch that occurs at 
this point because fluid has a higher impedance than air, so it takes more energy to push the 
sound through fluid. The auditory system accounts for the mismatch in two ways: (a) the 
tympanic membrane surface area is much larger than the oval window surface area, and (b) the 
incus and malleus are constructed to act as a lever system. These two methods work to amplify 
the sound pressure wave to overcome the impedance mismatch that occurs when moving the 
energy from air through fluid (Njaa et al., 2012). The Eustachian tube in canines extends from 
the tympanic cavity proper in the middle ear cavity to the nasopharynx. The Eustachian tube has 
the same pressure equalization function in the middle ear of canines as it does in humans (Cole, 
2009). 
 Continuing to move medially through the canine auditory system, the inner ear is located 
in the petrous section of the temporal bone of the canine (Cole, 2009). The middle ear connects 
to the inner ear via the oval window and the round window. The stapes footplate fits into the oval 
window and when the sound is transferred through the ossicles, the footplate transforms the 
energy to the fluid in the inner ear. The inner ear consists of the vestibule, three semicircular 
canals, and a cochlea that is spirally shaped. The canine inner ear has two main functions: to 
detect head movement and to detect sound. The utricle and saccule are responsible for detecting 
linear movement of the head and its position when static. The semicircular canals also detect 
movement from head position rotation. The cochlea is responsible for sound detection (Cole, 
2009). The coil of the cochlea is filled with fluid and is separated into different compartments 
called the scala vestibuli and the scala tympani. In between these two compartments is the scala 
media, which is separated from the scala vestibuli and the scala tympani by Reissner’s 





organ, sits on the basilar membrane. The cells on the organ of Corti are called hair cells and they 
move when the fluid above them moves (as a result of sound energy being transferred throughout 
the auditory system). The hair cells transmit the information they receive from the movement, 
which are afferent and efferent innervations from the cochlear branch of cranial nerve VIII (Njaa 
et al., 2012). This sends the signals to the brain to be processed as sound. The functions of the 
canine inner ear are similar to the functions of the inner ear in humans.  
 For canines, it was reported by Cole (2009) that responsiveness to sound begins at day 14 
on average after birth. The most utilized way to measure the responses to sound in canines is 
through auditory evoked responses. The method used currently is called the BAER test. Analysis 
of wave peaks I, II, III, and V, wave latencies, interpeak latencies, peak amplitudes, and 
thresholds help to determine hearing status in canines. It was found that by day 40, canines 
reached adult values of the BAER test (Cole, 2009). 
 Canine’s hearing sensitivity does differ from human’s hearing sensitivity in several ways. 
The frequency range audible to canines is approximately 67 Hz to 45k Hz according to Strain 
(2012), which is a much greater range than humans (approximately 67 Hz to 23k Hz). Lipman 
and Grassi (1942) found that although the hearing sensitivity of canines was comparable to that 
of humans in the frequency range of 125-250 Hz, above 250 Hz canines had superior hearing 
sensitivity than humans. According to West (1985), another difference between canine and 
human auditory systems is canine cochleas have approximately 3¼ turns whereas human 
cochleas have on average 2¾ turns. West reported that the number of turns in the cochlea is 
related to the range of audible frequencies and basilar membrane length is related to the limits of 
hearing on each end of the range. Increasing the number of turns in the cochlea could potentially 





fact that canines have more turns in their cochleas than humans and they have a larger range of 
audible frequencies. Although there are anatomical and physiological aspects of canine auditory 
system that are similar to the human auditory system, the differences mentioned above are 
important to note as they can alter hearing sensitivity. 
Types of Hearing Loss in Canines 
Conductive Hearing Loss 
 Conductive hearing loss occurs when a pathology is present in the outer and/or middle 
ear that prevents sound from traveling to the inner ear, which still functions adequately. The 
prevention of sound from traveling through the outer ear might be due to foreign objects, 
excessive cerumen blocking the ear canal, otitis externa (infection located in the ear canal), 
inflammation of the ear canal, or atresia (narrowing or lack of ear canal opening; Strain, 2012). 
Middle ear pathologies that might cause a conductive hearing loss are otitis media/primary 
secretory otitis media (infection in the middle ear), middle ear polyps, and potentially 
otosclerosis (Strain, 2012). A majority of the causes of conductive hearing loss are able to be 
fixed or treated through surgery, medication, or removal. If the inner ear is functioning normally 
and the outer or middle ear pathology has been corrected, then the canine’s hearing would be 
within normal limits. 
Sensorineural Hearing Loss 
 Sensorineural hearing loss occurs when a pathology is present that impacts the function 
of the hair cells and/or neurons in the cochlea and/or the vestibulocochlear nerve (CN VIII). 
Some causes of sensorineural hearing loss are congenital: pigment-associated and non-pigment-
associated hearing loss, perinatal anoxia, dystocia, and intrauterine ototoxicity exposure (Strain, 





drugs/chemicals that are toxic to the inner ear), otitis interna (infection in inner ear), noise-
induced hearing loss, presbycusis (age-related hearing loss), trauma, anesthesia-associated 
hearing loss, or hearing loss due to unknown cause(s; Strain, 2012). At this time, sensorineural 
hearing loss in canines cannot be corrected. Damage to the hair cells, neurons, or 
vestibulocochlear nerve is permanent most of the time.  
Distortion Product Otoacoustic Emissions Testing 
Otoacoustic emissions (OAE) testing is not a test of hearing sensitivity; it is an objective 
test of cochlear function. Evoked OAEs are emissions produced as a result of an acoustic 
stimulus. The outer hair cells in the cochlea respond specifically to the sound produced in the 
ear, which evokes a specific response that can be measured. The specific response of outer hair 
cells is referred to as outer hair cell motility, which is the elongation and compression of outer 
hair cells in response to sound stimulation. This motility along with the movement of the basilar 
membrane causes a cochlear amplifier effect. The cochlear amplifier effect is the location on the 
basilar membrane where there is a boost of energy at the place of maximum displacement when 
sound stimulation causes a forward traveling wave. Traveling waves always move base to apex 
because of the width of the basilar membrane (base thinner than apex) and the stiffness gradient 
(base stiffer than apex), which means the high frequencies at the base always respond first and 
low frequencies at the apex take longer to respond. For every frequency, there is a specific place 
of maximum displacement, meaning the location of the peak is dependent on frequency (Dallos, 
1988). Only healthy ears have the cochlear amplifier effect, which is responsible for exquisite 
hearing ability to differentiate frequencies and improve the dynamic range. When the ear is 
oxygen deprived or experiences damage, the outer hair cells are lost first, resulting in the loss of 





hearing, when damage occurs that causes loss of outer hair cells, the individual experiences 
approximately 50-60 dB of hearing loss and reduced frequency resolution due to the loss of the 
cochlear amplifier effect. The method for measuring the cochlear amplifier effect clinically is 
through OAEs. The OAEs are a direct measure of the motility of outer hair cells. External sound 
sources cause forward traveling waves toward the apical end of the cochlea in addition to reverse 
traveling waves that travel back toward the basal end of the cochlea, back through the middle ear 
to re-excite the tympanic membrane, and produce tiny sounds/emissions in the ear canal (Kemp, 
1986). The forward traveling wave at the place of maximum displacement on the basilar 
membrane causes a process to occur where the metabolic energy pool feeds the energy of the 
vibrations to travel backwards in what is called a backward traveling wave (Dallos, 1988). The 
pathway consists of the energy flow moving forward through the auditory system; then at the 
outer hair cell location, it reverses and flows back out to the external ear and acoustic 
environment (Dallos, 1988).  
There are different types of evoked otoacoustic emissions testing, one of which is called 
distortion product otoacoustic emissions (DPOAE) testing. “DPOAEs actually comprise a 
mixture of backward-traveling waves that arise by two fundamentally different mechanisms 
within the cochlea” (Shera & Guinan, 1999, p. 791). Otoacoustic emissions emerge from two 
mechanisms: the source of distortion near f2 and coherent reflection near the distortion product 
frequency (Shera & Guinan, 1999). Distortion products are the vector sum of two components 
generated from the nonlinear distortion as well as the linear (coherent) reflection (Botti et al., 
2016; Shera & Guinan, 1999; Zelle et al., 2015). Linear (coherent) reflections are backward-
traveling waves that occur as a result of cochlear anatomy and mechanics producing random 





distortion is where the two-tone stimulus causes a nonlinear response by the cochlea. The 
forward-traveling waves create spatial distortions that become the sources of the backward-
traveling waves (Shera & Guinan, 1999).  
Otoacoustic emissions testing provides insight into how the outer hair cells in the cochlea 
are functioning. The test is ear specific as it tests each ear individually and results are shown for 
each ear. It is not a direct test of hearing sensitivity; however, research has shown relationships 
between DPOAE measures and hearing status. As a result, DPOAE testing can be used for 
screening or diagnostic purposes. A quick screening can be performed to get a basic idea of the 
status of overall cochlear function. A more in-depth diagnostic test can provide specific 
information regarding the functioning ability of the cochlea as well as provide indications for 
hearing status. Gorga et al. (1997) found DPOAEs accurately corresponded to hearing status for 
the 1500-6000 Hz frequency range with slightly less accurate agreement to the audiogram for 
frequencies above and below that range. It was shown that DPOAE measures had a relationship 
to audiometric thresholds where hearing losses less than 60 dB HL could be accurately identified 
through DPOAEs (Gorga et al., 1997). 
To perform evoked OAE testing, a probe that contains a microphone is fit into the ear 
canal of the patient. The probe presents a stimulus (two pure tones for DPOAEs), which causes a 
healthy cochlea to produce OAEs in response to the stimulus. The emissions travel back from the 
cochlea to the ear canal where they are measured and recorded by the probe microphone and 
displayed on a computer system. Distortion product otoacoustic emissions are commonly used in 
clinical settings to assess cochlear function (Abdala & Visser-Dumont, 2001; Gorga et al., 1997; 





Distortion product otoacoustic emissions are OAEs evoked in response to two tones at 
different frequencies (f1 and f2 where f2 > f1) produced simultaneously typically at two different 
levels (L1 and L2 where L1 > L2). When testing humans, the L1/L2 levels are typically 65/55 
decibels (dB) sound pressure level (SPL; Marcrum et al., 2016). Fitzgerald and Prieve (2005) 
found that with primary levels (L2) ranging from 60 to 70 dB SPL, the mean amplitudes of the 
DPOAE responses were the highest. The two tones interact with each other and result in 
additional tones that are mathematical combinations (or distortion products) of both tones, one of 
which is 2f1-f2 (Marcrum et al., 2016). Humans with normal hearing generally have the most 
robust response at the 2f1-f2 distortion product (Christensen et al., 2015). The most robust 
distortion product is thought to occur when the excitation patterns produced by each primary 
tone have the greatest overlap (Marcrum et al., 2016). This overlap occurs between the f1 and f2 
frequencies and is somewhat closer to f2. For that reason, the DP-gram is plotted with f2 on the 
horizontal axis. Distortion product otoacoustic emission tests examine OAEs in the frequency 
range of 0.8 to 8k Hz (Lonsbury-Martin et al., 1995). Otoacoustic emissions are evoked at or 
near frequencies where hearing thresholds are normal or near to normal (Kemp, 2002).  
Extrinsic and intrinsic factors can affect OAE results. Extrinsic factors relate to 
influences that occur outside of the patient and intrinsic factors are variables within the patient. 
These factors can co-occur, or not, and impact the results from OAE testing. 
Extrinsic Factors Affecting Distortion  
Product Otoacoustic Emissions 
Monitoring cochlear function through DPOAEs means test consistency must be high and 
other factors that would negatively impact the reliability need to be taken into consideration 
when testing multiple times (Dreisbach et al., 2017). It is typical for there to be some degree of 





8 dB between tests for the frequency ranges of 1 to 6k Hz or 6.5 to 7k Hz, respectively 
(Dreisbach et al., 2017). Dreisbach et al. (2017) and Kemp (2002) reported that positioning of 
the probe and probe fit had a huge impact on reliability and intensity of the OAE response, or 
lack thereof, between numerous tests. Re-seating the probe or altering placement between tests 
has an effect on variability as well since it could change background noise levels and affect how 
the resonances of the ear canal interact with the stimulus (Dreisbach et al., 2017). Background 
noise levels of greater than 40 dB could negatively impact OAE results (Kemp, 2002; Kemp et 
al., 1990). In terms of the types of background noise, continuous sounds and reverberant sounds 
are larger issues than sudden short sounds, which could be rejected by the equipment as the 
testing continues (Kemp, 2002). To help reduce background or ambient noise in the room, 
ensuring a good probe fit is imperative. An airtight seal reduces external noise and establishes 
correct positioning of the ports responsible for transmitting the signals to be fully facing the 
tympanic membrane and not blocked by the canal wall (Kemp et al., 1990).  
Intrinsic Factors Affecting Distortion  
Product Otoacoustic Emissions 
Intrinsic factors are factors that occur within the patient. The health status of the patient 
can be a factor in variability. The position of the patient could influence test-retest reliability 
since changing positions between tests could impact DPOAE magnitudes and cause variation 
between tests (Voss et al., 2006). Voss et al. (2006) reported DPOAEs decreased in magnitude as 
posture went from upright to horizontal. Excessive cerumen, fluid in the middle ear, and 
infections are other factors that could prevent successful and accurate OAE recordings (Kemp, 
2002). Hearing sensitivity status could also impact OAE testing as a conductive hearing loss 
could prevent OAEs from being present or measurable. Significant sensorineural hearing loss 





Some other intrinsic factors that could impact DPOAE responses result from the 
vulnerability of the outer hair cells in the inner ear of the auditory system. Because of the 
vulnerability of outer hair cells to anoxia, ototoxic substances, and noise, if damage occurs, then 
it could impact DPOAE responses. As soon as the ear loses access to oxygen, it becomes 
damaged because it causes the auditory system to have blood supply loss. The outer hair cells are 
the first structures to become damaged and/or lost with loss of oxygen. Outer hair cells are 
especially vulnerable to ototoxic substances and could become damaged and/or lost when 
ototoxic substances are introduced into the body. Exposure to excessive sound levels could cause 
damage and/or loss of outer hair cells, which could result in a reduction of OAE responses (Hall, 
2000; Robinette & Glattke, 2007). 
F1 and F2 Distortion Product Otoacoustic  
Emission Stimulus Tones 
Because OAEs are frequency-specific responses, the measured frequency from an OAE is 
significant (Kemp, 2002). The primary location the 2f1-f2 generates on the basilar membrane is 
in the region of the f2 frequency (Zelle et al., 2015); then the generation travels to the basal end 
of the cochlea and out through the middle ear to the ear canal where it is measured. It was found 
that when the f1 and f2 levels were equal in dB SPL, the location of f2’s peak was greater in 
intensity than f1 (Kemp, 2002). Therefore, by making f1 a greater intensity, the peak would shift 
to the location of f2’s peak (Kemp, 2002; Zelle et al., 2015). The peak of f2 changes according to 
different frequencies and there is a complex interaction between f1 and f2 levels that varies with 
changes in frequency (Zelle et al., 2015). This would increase the production of distortion 
products. For humans, there is an ideal stimulus intensity ratio (f2: f1) to get the maximum 
production of distortion products (Kemp, 2002). “The extent to which all the elemental OHC 





backwards DP travelling wave (and hence a DPOAE) depends on the spatial distribution of DP 
phases” (Kemp, 2002, p. 234). The velocities of the traveling waves of f1 and f2 are what 
determines if the distortion product produces or does not produce a DPOAE response.  
When the velocity ratio of f1 and f2 is one, or close to one (i.e., 1.02), the traveling wave 
velocities are very similar, resulting in a wave that travels toward the apical end of the cochlea. 
This means not much of a traveling wave gets sent back to create a DPOAE. With a large f2/f1 
ratio (i.e., 1.5) the distortion product phase distribution would mostly cancel itself out, causing 
very small spreading of the distortion product wave. It was found that there is an optimum f2/f1 
ratio for humans, around 1.2, that causes distortion product distribution to create a traveling 
wave moving backward over the outer hair cells (Kemp, 2002). Harris et al. (1989) found that at 
a low ratio of around 1.01, DPOAEs decreased until they reached a minimum amplitude and that 
as the ratio increased in the 1.18 to 1.28 range, the DPOAEs increased until they reached a 
maximum amplitude. If the ratio increased past the one that elicited the maximum peak 
amplitude response (range of 1.4), the DPOAE again decreased until it reached a minimum 
amplitude. Currently, for humans, the ratio of f2/f1 is typically 1.2 to 1.25 for clinical use 
(Abdala, 1996; Abdala & Visser-Dumont, 2001; Knight & Kemp, 2000). With the ratio around 
1.2-1.25 between the two stimulus tones, it allows for the forward traveling waves to produce a 
backward traveling wave with the greatest amplitude to then be measured by the OAE 
equipment. It was found this ratio allowed for OAE test results on humans to have the greatest 
amplitudes and best recordings.  
Additionally, it is known that mammalian ears, including human ears, do not only 
produce the 2f1-f2 distortion product. Multiple distortion products are produced; however, it has 





Therefore, the 2f1-f2 distortion product is the distortion product that is recorded in human ears as 
standard practice. It is possible that due to differences in ear anatomy and physiology, canine 
ears might respond differently than human ears to probe frequencies f1 and f2. As a result, 
canine ears might produce distortion products at different mathematical combinations than 
human ears. It is theorized the distortion product mathematical combination might be larger in 
canine ears because of the size differences in ear anatomy compared to humans. Further study is 
necessary to determine if canine ears produce distortion products at levels that vary compared to 
humans. 
Test Protocol 
Otoacoustic Emission Equipment 
 The probe is designed to bring the transducer within millimeters of the probe tip to get 
good responses and frequency bandwidths for a variety of ears (Kemp et al., 1990). The probe tip 
is a rubber tip or a disposable foam tip (Knight & Kemp, 2000) that fits on the end of the probe. 
It is set into the ear canal to the point where the rubber flange on the tip is fully compressed to 
create a seal (Kemp et al., 1990). The probe contains ports that produce the stimuli and receive 
the signals transmitted back into the canal. The probe needs to be placed deeply in the ear canal 
for maximum OAE responses and maximum noise levels are reduced (Kemp, 2002). Distortion 
product otoacoustic emission stimuli consist of two pure tones; typically, the lower frequency 
tone is produced at 60-70 dB SPL and the higher frequency tone is produced at a lower level of 
50-70 dB SPL (Kemp, 2002). Since OAEs are very low-level sounds, any external sounds above 
40-45 dB SPL could trigger the data to be rejected (Kemp et al., 1990) so an environment with 
low levels of ambient noise is necessary to perform OAE testing. Noise that is lower in level (not 





what is noise through the signal components in a process called signal averaging. For example, 
low level noise is unrelated in phase and frequency content in comparison to the stimuli and 
when the signals are averaged together, it will cancel out the noise (Kemp et al., 1990). Even 
though the system could discriminate noise from stimuli and emissions through signal averaging, 
tests still need to be run multiple times to confirm the noise has in fact been eliminated 
appropriately (Kemp et al., 1990). 
Distortion product otoacoustic emissions are recorded on what is called a DP-gram. The 
DP-gram is a display of the amplitude as a function of the frequency of f2 (Abdala & Visser-
Dumont, 2001). The frequency plotted on the DP-gram is generally the frequency of the f2 
primary tone, not the frequency of the DPOAE, because past research found the interaction of 
the primary tones occurred where the traveling waves of the primary tones overlapped the most 
(Robinette & Glattke, 2007). Where the primary tones overlap the most is between the f1 and f2 
frequencies, with the tendency to be closer to f2, which is why the DP-gram is plotted with f2 on 
the horizontal axis. The DP-gram records information of the OAE as well as the level of 
background noise—called the noise floor. A DPOAE is present (considered a pass) if the level of 
the DPOAE plus the noise floor is greater by a criterion amount (e.g., 6 dB) than the average 
noise level (Robinette & Glattke, 2007). A DPOAE test is considered absent or present but 
abnormal when a response is not present for at least two f2 frequencies (Abdala & Visser-
Dumont, 2001). 
Mutt Muffs 
Mutt Muffs® (Safe & Sound Pets, 2021) might help reduce ambient noise in the 
environment that could prevent OAEs from being accurate and repeatable. Mutt Muffs provide 





consists of circumaural muffs that are connected by a strap that could be adjusted based on the 
canine’s head size. Mutt Muffs come in different sizes to accommodate different breeds and 
sizes of dogs (Safe & Sound Pets, 2021). According to the manufacturers of Mutt Muffs, the 
inner foam on the muffs is the same foam that is used in high end commercial headsets for 
humans. They estimate the reduction level is approximately 25 to 28 dB with the manufacturers 
assuming there is a good seal of the muffs against the canine’s head and a good fit completely 
around the ears (Safe & Sound Pets, 2021). The manufacturers did state the only data they had 
was through 20,000 Hz, which is not the complete range for canine hearing. This covers the 
range for humans; however, canines can hear from approximately 67 Hz to 45k Hz (Strain, 
2012). Since there are no data on the higher frequencies, the manufacturers could not be sure of 
the decibel reduction at those higher frequencies; however, they said the effectiveness of the 
Mutt Muffs increased as the frequency of the stimulus increased since higher frequencies were 
more easily absorbed (Safe & Sound Pets, 2021). The Mutt Muffs manufacturers claimed that 
canines with pendulous ears had another layer of protection since the pinnae were pressed down 
by the Mutt Muffs, which covered the ear canal; however, no data confirmed this. 
Overview of Otoacoustic Emissions in Canines 
 Otoacoustic emissions testing could provide important and useful information regarding 
the integrity of the canine’s auditory system (Schemera, 2011). Two types of emissions testing 
are used for diagnostics and screenings: transient evoked otoacoustic emissions (TEOAE) testing 
and DPOAE testing. Transient evoked otoacoustic emissions testing uses transient stimuli (e.g., 
clicks) and DPOAE testing uses pairs of tones (Schemera, 2011). It is currently not common for 
DPOAE or TEOAE assessments to be used in private veterinary offices (Schemera, 2011). There 





a study of DPOAEs in clinically normal alert puppies (Schemera, 2011), preliminary findings of 
TEOAEs and DPOAEs in canines (Sockalingam et al., 1998), TEOAEs and DPOAEs in canines 
to assess cochlear hearing status (Goncalves et al., 2012), DPOAEs in geriatric dogs (Strain et 
al., 2016), and deafness detection in puppies using an OAE screener (Sims et al., 2017). Table 1 
provides a summary for each of the aforementioned studies followed by a more detailed 






Table 1  
 












• Noise-reducing ear 
cover over canine’s 
ears 
• TEOAE stimulus 
level: 90 dB SPL 
• DPOAE stimulus 
level: 75/55 dB SPL 
• F2/f1 ratio: 1.21 
• Two groups: first had DPOAEs and TEOAEs compared, second 
had OAEs and BAER compared 
• 19 breeds, 3 months-10 years old, 5-50 kg 
• TEOAEs and DPOAEs successful in determining hearing status 
in canines 
• Able to get accurate TEOAE and DPOAE results and accurately 
identified pass for ears where BAER responses present, and refer 
for ears where BAER responses were not present 
     
Schemera 
(2011) 
23 DPOAE • Acceptance 
criterion: result 8 dB 
or greater above 
noise floor 
• F2/f1 ratio: 1.20 
• Stimulus levels: 
65/55 dB SPL 
• 13 mm foam probe 
tip 
• 7.5-10.5-week-old puppies with normal hearing sensitivity 
• DPOAEs were robust, repeatable, and reliable 
• DPOAEs in agreement with BAER behavioral testing results 
• Mean DPOAE amplitudes not significantly different between 
ears 
• Mean DPOAE amplitudes not significantly different between 
genders 
• Amplitudes of DPOAEs increased significantly as f2 increased, 
in both left and right ears 
• Concluded that DPOAE absolute amplitudes of puppies were 
comparable to previously recorded of adult canines (anesthetized) 
     




• 13 mm foam probe 
tip 
• Stimulus levels: 
65/55 dB SPL 
• Puppies 6-10 weeks old 
• All ears with normal BAER test results had DPOAE results 
that were a pass 
• Ears with flat BAER test results had DPOAE results that 
were a refer 
• Concluded DPOAE screening can reveal pass/refer results 
















F2/f1 ratio: 1.22 • Adult canines with normal hearing sensitivity 
• Able to use human test specifications to get TEOAE results 
• Adjustments to SNR for DPOAEs were necessary to get 
results 
• Stimulus levels to produce DPOAEs found to be 55/55, 
55/45, and 55/35 
• TEOAEs and DPOAEs recorded twice without removing 
probe for repeatability 
• Reproducibility of TEOAEs had variability  
• No consistent configuration of frequency spectrum between 
dogs for TEOAEs 
     




• 9 mm or 10 mm 
probe tip 
• Stimulus levels: 
65/55 dB SPL 
• F2/f1 ratio: 1.21 
• Geriatric canines (mean age 12.2  2.2 years) 
• Control group of adult canines (5.9  3.0 years) 
• Compared BAER responses to DPOAE responses 
• Found significant decreases in DPOAE response amplitudes 
for 6-12k Hz in geriatric canines (compared to control 
group) 
• BAER responses similar to DPOAE responses: both 
decreased for geriatric population 
• Concluded DPOAE testing on canines could be used to 
track hearing changes with age in canines 








Sockalingam et al. (1998) reported successful recording of DPOAEs and TEOAEs in the 
ears of seven canines with normal hearing sensitivity. The purpose of the study was to get 
preliminary results on TEOAEs and DPOAEs in dogs and determine some basic characteristics. 
The researchers used the default settings for testing TEOAEs in humans and were able to get 
results in 92% of canine ears tested (Sockalingam et al., 1998). When Sockalingam et al. tested 
TEOAEs using the quick screen tool, they were able to get results in 100% of the canine ears. 
The researchers reported they were able to use human test specifications to get results for 
TEOAEs but adjustments of the signal-to-noise ratio (SNR) had to be made for measuring 
DPOAES in canines. The researchers found the stimulus levels to produce DPOAEs were 55/55, 
55/45, and 55/35 dB SPL after looking at eight different stimulus levels (L1/L2: 70/70, 65/65, 
65/55, 60/60, 55/55, 65/45, 55/45, 55/35 dB SPL; Sockalingam et al., 1998). The f2/f1 ratio was 
set at 1.22 with the researchers reasoning the ratio of 1.22 provided the most robust DPOAEs in 
humans and some laboratory animals. For all the testing, the researchers placed a B type probe 
designed for adults in the canine ear canal. Both TEOAEs and DPOAEs were recorded twice 
without moving the probe to confirm repeatability. The reproducibility for TEOAEs had a large 
range of variability but the average percentage was above 60%, which was the criterion at the 
time of the study to determine if TEOAEs were present in humans. Sockalingam et al. concluded 
there was no consistent configuration of frequency spectrum between the dogs for TEOAEs. 
Size, age, breed, and ear canal size were not controlled for this study and Sockalingam et al. 
recommended that further study be performed to provide more detailed information about 
TEOAEs and DPOAEs in canines. 
 In 2011, Schemera evaluated DPOAEs in 23 puppies with normal hearing aged 7.5-10.5 





repeated one to two times for repeatability measures. The criterion for acceptance of the result 
was required to be 8 dB or greater above the noise floor. The DPOAEs were robust, repeatable, 
reliable, and in agreement with auditory brainstem (BAER testing) and behavioral testing results. 
Stimulus levels of 65 (f1) and 55 (f2) dB SPL and an f2/f1 ratio of 1.2 were used for the study. 
The probe tip consisted of a 13mm foam tip that was trimmed to allow the tubing port in the 
center of the foam tip to sit flush with the probe assembly port, all of which were attached to the 
probe unit. The foam tip was placed at the entrance to the horizontal portion of the puppies’ ear 
canals. The results from the study were as follows: mean DPOAE amplitudes were not 
significantly different between ears (left and right) and mean DPOAE amplitudes were not 
significantly different between genders (male and female). They did find the amplitudes of the 
DPOAEs increased significantly as f2 increased in both the left and right ears of the canines. 
Schemera concluded the DPOAE absolute amplitudes of the puppies were comparable to those 
previously recorded of adult canines that had been anesthetized. The results were indicative that 
DPOAE testing could be performed on puppies and that accurate, repeatable, and reliable results 
could be obtained. 
 In 2012, Goncalves et al. performed a study evaluating hearing status in canines through 
the use of TEOAEs and DPOAEs. The researchers performed testing on two groups of 
anesthetized dogs: the first group had their OAE results compared to BAER test results and the 
second group had their TEOAE responses and DPOAE responses compared. The 53 canines 
were a combination of males and females, consisted of 19 breeds, ages were 3 months to 10 
years, and ranged in weight from 5 to 50 kg. They found TEOAE and DPOAE testing was 
successful in determining hearing status in canines (deaf or hearing). The researchers used probe 





noise-reducing ear cover from Parkson Safety Industrial Corporation loosely over the canine’s 
ear (manufacturer stated noise reduction of 31-37.9 dB). The stimulus level for TEOAEs was 90 
dB SPL. For DPOAEs, the stimulus levels were 75 dB SPL for f1 and 55 dB SPL for f2, and the 
frequency ratio of f2/f1 was 1.21. Goncalves et al. concluded that through using similar criteria 
for pass/fail of OAEs, they were able to get accurate TEOAE and DPOAE results and accurately 
identified a pass for ears where BAER responses were present and a refer for ears where BAER 
responses were not present. The researchers reported that further research needed to be 
performed to determine optimal pass/refer criteria for canines.  
 In contrast to Schemera (2011), Strain et al. (2016) evaluated DPOAEs in 28 geriatric 
canines. Strain et al. conducted DPOAE testing on geriatric canines (mean age of 12.2 with a 
standard deviation of  2.2 years). A control group of adult canines (5.9  3.0 years) was also 
tested for comparison of frequency-specific changes in the cochlear responses seen through 
DPOAEs. They used a 9mm or 10mm probe tip for the DPOAE testing and the stimulus levels 
were 65 dB SPL and 55 dB SPL for f1 and f2. The f2/f1 ratio was 1.21. The frequency range 
tested was six primary frequencies at 2k Hz intervals from 2-12k Hz. A minimum of two 
DPOAE tests were run for each ear to confirm repeatability. In addition, the researchers 
measured BAER responses to compare to the DPOAE results. Strain et al. found significant 
decreases in DPOAE response amplitudes in the frequency range of 6-12k Hz in the geriatric 
canines when compared to the control group of adult canines. The researchers reported the 
BAER responses were similar to the DPOAE responses as both decreased for the geriatric 
population. When the DPOAE results had small amplitudes, the BAER testing results 
corresponded with reduced amplitude as well. The geriatric canine population had a significant 





coincided with aging changes that become present in the geriatric population of canines. Strain et 
al. concluded that DPOAE testing on canines could be used to track hearing changes with age in 
canines. 
 In 2017, Sims et al. tested 34 puppies using DPOAEs with the purpose of deafness 
detection. The puppies were aged 6-10 weeks old, both male and female from a variety of 
breeds, and the DPOAE responses were compared to BAER test results. Sims et al. found that in 
all the ears with normal BAER test results, the DPOAE results were a pass. Puppies that had flat 
BAER test results had DPOAE results that were a refer. Sims et al. used a 13mm foam probe tip 
and a handheld DPOAE screener to perform the testing on the puppies. The stimulus levels were 
65 dB SPL and 55 dB SPL for f1 and f2, respectively. Sims et al. concluded that although the 
Orthopedic Foundation for Animals reported BAER testing was the only acceptable hearing 
assessment method for canines, DPOAE screening could reveal pass/refer results that were in 
agreement with BAER test results and were not affected by age, sex, breed, state of 
consciousness, or ear canal size. 
 Scheifele and Clark (2012) noted in their description of electrodiagnostic evaluation of 
auditory function in canines that one of the issues regarding performing OAEs on canines was it 
was difficult to get a good seal of the probe tip. Lack of a good seal meant poor SNRs, 
discomfort for the canine, and inability to get accurate and repeatable results. Scheifele and Clark 
concluded that although BAER testing has been the method used to determine hearing status in 
canines in veterinary offices, with better data, protocol, and equipment, OAEs could be of use to 
veterinary clinics to perform hearing screenings on canines as well as diagnostic evaluation in 





 Current research delved into OAEs in canines; however, still considerable information 
was missing. For diagnostic and screening purposes, it is imperative that norms and guidelines be 
determined. This would allow clinicians to get accurate test results when conducting OAEs on 
canines, which would result in more accurate diagnoses of canines’ hearing sensitivity. 
Specifically, DPOAEs rely on specific f1 and f2 ratios, signal levels, probe fit, environmental 
specifications, and patient cooperation. Complex interactions exist among all these variables and 
there are still unanswered questions regarding exactly where along the basilar membrane the 
DPOAE is generated in human ears. As aforementioned, the canine cochlea contains more turns 
than humans, which means their basilar membrane is likely longer. This could be the reason 
canines have a larger range of frequencies audible to them. With this information, it could be 
inferred that the optimal f2/f1 ratio might be different than it is for humans since for humans, it is 
specifically related to the basilar membrane length, basilar membrane distance between 
frequencies, and how the f1 and f2 frequencies create traveling waves. The aim of this study was 















Ten dogs with normal hearing were recruited for DPOAE testing. Each canine was tested 
once (during one session). The owners voluntarily brought the subjects to the University of 
Northern Colorado Speech-Language Pathology and Audiology Clinic. The canines chosen for 
the study were a convenience sample recruited through The Facility for Education and Testing of 
Canine Hearing and Laboratory for Animal Bioacoustics (FETCHLAB) at the University of 
Northern Colorado. No attempt was made to control for breed or gender. Inclusion criteria were 
the canines must be between the age of two and eight years old, weigh 10-90 lbs. due to 
limitation of the size of available Mutt Muffs, and have essentially normal hearing sensitivity 
confirmed through robust and repeatable DPOAE responses during testing. Case history was 
acquired for each canine to confirm there were no current conditions that could have negatively 
impacted testing (i.e., cerumen impaction, otitis media, etc.). Performance of DPOAE testing of 
canines at FETCHLAB at the University of Northern Colorado was approved by the Institutional 
Animal Care and Use Committee, which is responsible for determining research is ethically and 







Test Environment, Procedure, and Instrumentation 
Testing was performed using the Otodynamics Ltd. ILO-v6 clinical OAE software 
(serial# DP4/04/0132/11) with up-to-date calibration (calibrated within 12 months of testing). 
Figure 1 provides an image of the software. 
 
Figure 1 






Mutt Muffs (Safe & Sound Pets, 2021) were utilized to help reduce ambient noise levels 
because the probe tips were not designed specifically to fit the canine ear. This could result in 
lack of the probe tip creating a complete seal; therefore, ambient noise would potentially be a 
larger factor for canines. The appropriate size of Mutt Muffs used during testing was determined 





Muffs were determined to be necessary for testing purposes to reduce ambient noise in the 
testing environment. The ILO-v6 software was set up to perform a diagnostic DPOAE test. 
Distortion product otoacoustic emissions testing was performed on the right ear only for each 
canine. The testing environment was a single-walled sound-treated booth, Tracoustics acoustical 
enclosure (serial# 477-076068), in the University of Northern Colorado Speech-Language 
Pathology and Audiology Clinic. 
Distortion product otoacoustic emissions were performed on all 10 canines without the 
use of sedation or anesthesia. Otoscopy was utilized to confirm the ear canal was clear and to aid 
in selection of an appropriately sized rubber probe tip from Otodynamics Ltd. The OAE probe 
tips of various sizes (Type R9M, R11M, R13M) came in blue and white and specifically 
designed for use with the ILO-v6 clinical OAE software system (see Figure 2).  
 
Figure 2 









The probe tip was attached to the probe and subsequently inserted into the vertical 
portion of the ear canal to the ridge where it turned into the horizontal canal. The adequately 
sized Mutt Muffs (Safe & Sound Pets, 2021) were placed and secured with Velcro to cover the 
ear being tested. Two attempts to conduct DPOAEs using an optimal f2/f1 ratio of 1.22 for 
humans (Abdala & Visser-Dumont, 2001; Knight & Kemp, 2000) were completed using the 
ILO-v6 software system to confirm reliability of the initial test results. The settings were kept the 
same for each test on every canine. The L2 was fixed at 55 dB SPL and the L1 was fixed at 65 
dB SPL. The f1 was varied to produce nine total f2/f1 frequency ratios while f2 remained fixed. 
A calibration test was run prior to testing each canine. For each test, there was an initial check-fit 
test. To pass the check-fit test, there needed to be at least 30 good check-fit sweeps. When the 
test was being performed, the minimal criterion was two DP loops with a minimum response 
level in dB of -10. The test automatically timed out at three minutes. The noise reject level was 
set to 10 dB SPL1. The stopping criteria for the testing was two completed DP loops. If the 
canine moved or vocalized during the testing but did not affect the responses or noise floor, the 
testing continued. If canine movement or vocalizations resulted in the noise floor going above 10 
dB SPL1 for two to three frequencies, then a third DP loop was performed. If the canine 
continued to have movements or vocalizations that caused more than three frequencies to have 
noise floors above 10 dB SPL, then the testing was stopped and restarted once the canine was 
cooperative. When two repeatable responses were initially obtained, the f1 was then altered to 
produce the following f2/f1 ratios: 1.18, 1.20, 1.21, 1.22, 1.23, 1.24, 1.25, 1.26, and 1.28. There 
was one run of the diagnostic DPOAE test for each ratio and the test was only run a second time 
 
1 Originally 5 dB SPL, however this was quickly found to be unrealistic during data collection. 





if the response was impacted by the canine’s movement or vocalizations and an accurate 
response needed to be determined through repeatability. The order of the frequency ratios was 
randomized across the subjects. It was important to mention that once the probe tip was inserted 
and the Mutt Muffs were secure, the probe tip was not removed and reinserted. The DP chart 
type was a DP line graph with four points per octave from 1-8 kHz. The data were a DP-gram 
and the data recorded consisted of the absolute amplitude of the DPOAE and the SNR. The data 
were saved on the computer as well as copied onto a USB drive.  
Distortion product otoacoustic emissions results were collected once the probe was 
placed into the vertical canal portion of the canine’s ear canal and Mutt Muffs (Safe & Sound 
Pets, 2021) were placed securely around the head. Repositioning of the probe and Mutt Muffs 
was common and occurred when the subject shook his/her head in an effort to remove the 
equipment. There were numerous incomplete test runs for all of the test subjects, especially at 
the beginning of testing due to canine noise or movement that happened before the canine settled 
down. Incomplete test runs were not documented and were discarded at the time of data 
collection. Complete runs were obtained once the canine and the environment were conducive to 
accurate data collection. The DPOAE line graph representations for each f2/f1 ratio for all test 
subjects are in Appendix B. 
Descriptive and nonparametric statistics (Kruskal-Wallis test) were used to determine the 










Successful results were obtained for 10 out of 10 subjects for all 9 f2/f1 ratios. Table 2 
provides descriptions of subject demographics. Figure 3 illustrates the results from subject 4 for 
all f2/f1 ratios tested. 
 
Table 2 
Descriptions of Test Subjects 





1 Mix 7 Small (10-30) M 
2 Border Collie 4 Medium (30-55) M 
3 German Shepherd 3 Large (55+) M 
4 Mix 2 Medium (30-55) M 
5 Australian Shepherd 4 Medium (30-55) F 
6 Labrador Retriever 6 Large (55+) M 
7 Labrador Retriever 8 Large (55+) M 
8 Labrador Retriever 4 Large (55+) M 
9 Labrador Retriever 8 Large (55+) F 








Distortion Product Otoacoustic Emissions Response Line Graphs for Subject 4 for all Nine f2/f1 
Ratios Tested 
 
1.18 1.20 1.21 
   
1.22 1.23 1.24 
   
1.25 1.26 1.28 
   
 
 
The mean DPOAE amplitudes are displayed in Figure 4 and Table 3. Appendix C 







Average Distortion Product Otoacoustic Emissions Amplitude Values at Each f2 Frequency 






Mean Amplitudes in Decibel Sound Pressure Level for Each Frequency Tested 
 1k Hz 1.4k Hz 2k Hz 2.8k Hz 4k Hz 6k Hz 8k Hz 
M -0.513 -3.26 -2.456 2.741 9.09 17.303 10.881 
Minimum -2.06 -6.84 -3.96 1.46 5.94 15.12 9.28 
Maximum 1.72 -0.46 -1.52 5.05 11.34 19.85 13.45 
SD 1.336 1.945 0.895 1.188 2.064 1.689 1.315 
N = 9 
 
Figures 5-8 illustrate the amplitudes in dB for all f/2/f1 ratios for each subject at the 





































subjects 2, 3, and 6 had overall reduced amplitudes when compared to the other subjects. It also 
showed no significantly different amplitudes for different f2/f1 ratios. 
 
Figure 5 


































Amplitudes at 2.8k Hz for all f2/f1 ratios



























Amplitudes at 4k Hz for all f2/f1 Ratios












































Amplitudes at 6k Hz for all f2/f1 Ratios
























Amplitudes at 8k Hz for all f2/f1 Ratios





An analysis of variance was run to evaluate the statistical significance of amplitude 
across frequencies for the f2/f1 ratios tested (see Table 4). 
 
Table 4 
Amplitude Results from the Repeated Measures Analysis of Variance Using Pillai's Trace for 
Ratio and Frequency 
 
Effect Value F Hypothesis df Error df Sig 
Ratio 0.850 1.413 8.000 2.000 0.479 




Results showed no statistically significant differences in DPOAE amplitudes across 
ratios. The version of SPSS used was IBM SPSS Statistics, Version 25. Repeated measures 
analysis of variance (ANOVA) revealed a p-value of .479 (p < .05). On average, 6k Hz had the 
largest amplitude with a mean of 17.303 dB, followed by 8k Hz with a mean amplitude of 10.881 
dB. At and below the frequency 2k Hz, the mean amplitudes were less than 0 dB. These results 
are depicted in Figure 8.  
In addition to amplitudes, noise levels were also analyzed. Noise level trends are 







Average Noise Values in Decibel Sound Pressure Level Across All Subjects at Each Frequency 







Noise Level for Each Frequency Tested 
 1k Hz 1.4k Hz 2k Hz 2.8k Hz 4k Hz 6k Hz 8k Hz 
M 5.277 1.937 -0.636 -2.498 -2.944 -4.523 -8.336 
Minimum 3.45 -0.95 -2.86 -4.18 -5.49 -6.65 -10.41 
Maximum 7.19 3.71 2.04 -0.59 -0.33 -2.7 -7.32 
RNG 3.74 4.66 4.9 3.59 5.16 3.95 3.09 













































An analysis of variance was run to evaluate the statistical significance of noise floor 
levels across frequencies for the f2/f1 ratios tested (see Table 6). 
 
Table 6 
Noise Floor Results from the Repeated Measures Analysis of Variance Using Pillai's Trace for 
Ratio and Frequency 
 
Effect Value F Hypothesis df Error df Sig 
Ratio 0.906 2.408 8.000 2.000 0.326 




Results showed no statistically significant differences in DPOAE noise floors across 
ratios. The version of SPSS used was IBM SPSS Statistics, Version 25. Repeated measures 
ANOVA revealed a p-value of .326 (p < .05). On average, 8k Hz had the lowest noise level with 
a mean of -8.336 dB, followed by 6k Hz with a mean noise level of -4.523 dB. At and below the 
frequency 1.4k Hz, the mean noise levels were above 1 dB. These results were depicted in Figure 
9.  
In addition to amplitude (in dB SPL), DPOAE results are reported clinically for signal-to 
noise-ratios, that is, how much larger than the noise floor the DPOAE response is. Signal-to- 







Average Distortion Product Otoacoustic Emissions Signal-to-Noise Ratios (in Decibels) Across 







Average Signal-to-Noise Ratio Values (in Decibels) Across All Subjects at Each Frequency 




























































An analysis of variance was run to evaluate the statistical significance of signal-to-noise 
ratios across frequencies for the f2/f1 ratios tested (see Table 7 for analysis results). 
 
Table 7 
 Signal-to-Noise Ratio Results from the Repeated Measures Analysis of Variance using Pillai's 
Trace for Ratio and Frequency 
 
Effect Value F Hypothesis df Error df Sig 
Ratio 0.863 1.574 8.000 2.000 0.445 
Frequency 0.932 9.151 6.000 4.000 0.025 
 
Results showed statistically significant differences in DPOAE SNRs across frequencies. 
The version of SPSS used was IBM SPSS Statistics, Version 25. Repeated measures ANOVA 
revealed a p-value of .025 (p < .05). The tables and figures above included absent responses 
(defined as <0 dB) for 2k Hz and below. On average, 6k Hz had the largest SNR with a mean of 
23.0567 dB, followed by 8k Hz with a mean SNR of 20.0989 dB. These results were depicted in 
Figure 10.   
Figure 11 depicted the SNRs at individual frequencies for all f2/f1 ratios. The SNRs at 1k 
and 1.4k Hz indicated absent responses. The SNRs at the frequencies of 2k Hz and above 
increased overall as the frequency increased with a maximum at 6k Hz. The f2/f1 ratio 1.23 had 
a smaller SNR at the frequencies 2k Hz and above when compared to the other f2/f1 ratios 
tested. The f2/f1 ratios 1.18 and 1.20 showed the largest SNRs for the frequencies of 2k Hz and 







Mean Signal-to-Noise Ratio Values for 2k Hz and Above (in dB) for Each f2/f1 Ratio 
f2/f1 ratio 1.18 1.20 1.21 1.22 1.23 1.24 1.25 1.26 1.28 
Mean SNR 
(in dB) 
15.33 16.30 13.83 13.37 10.20 12.95 12.62 12.12 11.70 
 
Statistical analysis showed no significant difference among the different ratios tested with 
a p-value of .445. Analysis did show frequency to be significant (p < .05) at 0.003 for amplitude, 
0.001 for noise, and 0.025 for SNR. This was to be expected based on what a typical DPOAE 
looked like. The response and noise floor would be different for different frequencies, which 
meant the SNR would also be different. The DPOAE responses are different for different 
frequencies, which was shown in the current study because responses at 1-2k Hz fell into the 
noise floor and higher frequencies had a large response.  
A post hoc analysis with the nonparametric Kruskal-Wallis test evaluated each frequency 
to determine if any of the f2/f1 ratios were significantly different from the others. It was found 
that none of the f2/f1 ratios were statistically significantly different from any other ratios at the 
specific frequencies of 2.8k, 4k, 6k, and 8k Hz with p-values at 0.989, 0.923, 0.883, and 0.986 (p 










DISCUSSION AND CONCLUSIONS 
Research Questions, Hypotheses, and Data 
Q1 When measuring distortion product otoacoustic emissions (DPOAEs) in canines, 
does the amplitude pattern across frequencies for the 2f1-f2 distortion product 
change with changes in the f2/f1 ratio? 
H1 The amplitude patterns across frequencies for the 2f1-f2 distortion product will 
vary with changes in f2/f1 ratio for canine DPOAEs. 
It was hypothesized that the amplitudes of the 2f1-f2 distortion product at the f2 
frequencies would vary with changes in the f2/f1 ratio. Results from the study suggested the 
amplitudes of the 2f1-f2 distortion products did not change across frequencies with changes in 
the f2/f1 ratio. Figure 10 illustrated that for all f2/f1 ratios tested, 6k Hz had the largest 
amplitude response, followed by 8k Hz. The responses below 6k Hz decreased as the frequencies 
decreased. There were minimal responses at the low frequencies, 1k Hz and 1.4k Hz. It could be 
concluded from this study that the amplitude patterns of the distortion products did not change 
significantly with changes in the f2/f1 ratio for ratios between 1.18 and 1.28.  
Q2 When measuring distortion product otoacoustic emissions (DPOAEs) in canines, 
do specific f2/f1 ratios produce different overall amplitudes of the 2f1-f2 
emission? 
H2 Changing the f2/f1 ratio produces different overall amplitudes of the 2f1-f2 
emission. 
It was hypothesized that changing the f2/f1 ratio would produce different overall 
amplitudes of the 2f1-f2 emission. Results from the study indicated that although there were 
differences in the amplitudes depending on the f2/f1 ratio, the differences were not statistically 





tested and the ratios 1.2 and 1.18 produced the largest amplitude 2f1-f2 emissions across all 
frequencies tested. Although Figure 10 indicated there were differences in amplitude when a 
Pillai’s Trace multivariate test was performed, the difference in the amplitudes was not 
significantly different when comparing the nine ratios tested in the study. It could be concluded 
from this study that f2/f1 ratios between 1.18 and 1.28 did not produce significantly different 
DPOAE elicitations of the 2f1-f2 emission in canines. 
Canine Hearing Frequency Range 
The range of audible frequencies for canines is approximately 67 Hz to 45 kHz, which is 
a much greater range than the range for humans at approximately 67 Hz to 23 kHz (Strain, 
2012). Canine cochleae have approximately 3¼ turns whereas human cochleas have on average 
2¾ turns (West, 1985). The number of turns in the cochlea is related to the range of audible 
frequencies and basilar membrane length is related to the limits of hearing on each end of the 
range (West, 1985). Increasing the number of turns in the cochlea could potentially increase the 
octave range the mammal can hear (West, 1985), which is illustrated through the fact that 
canines have more turns in their cochleas than humans and they have a larger range of audible 
frequencies. The accepted f2/f1 ratio for humans of 1.22 has to do with the anatomical properties 
of the human auditory system, specifically the basilar membrane and the number of turns of the 
cochlea as well as the frequency range of audibility. Canines have a longer basilar membrane and 
a larger number of turns of the cochlea as well as a larger range of audible frequencies. 
Therefore, it stands to reason the f2/f1 ratio that would produce the most robust DPOAE 






It appeared the canine DPOAE responses were robust at all ratios tested for 4k Hz 
through 8k Hz, which suggested the f2/f1 ratio did not affect clinical interpretation of results. 
Based on the results with a small sample size, the ratio that produced the largest overall DPOAE 
response was 1.20. It was unexpected that the f2/f1 ratios 1.20 and 1.18 would yield the largest 
SNR values across the frequency ranges tested with a mean SNR of 16.302 and 15.33 dB, 
respectively. The ratios 1.21 through 1.28 had a mean SNR range of 10.204-13.828 dB. Figure 
11 demonstrated SNR responses by frequency for each f2/f1 ratio tested and Figure 12 illustrated 
the SNR responses for each f2/f1 ratio at each frequency. The ratios 1.20 and 1.18 had the largest 
SNRs across all frequencies with clinically significant responses (above 2k Hz). Although 1.20 
and 1.18 had the largest SNRs across frequencies, the results were not statistically significant 
when comparing SNRs of different ratios.  
The f2/f1 ratio range was chosen because 1.22 is the typical f2/f1 ratio utilized for 
collecting DPOAEs in humans and due to knowledge of canine anatomy and audible frequency 
range, it was predicted the ratio producing the most robust responses would be larger but not 
excessively so. The f2/f1 ratios below 1.18 were not measured in this study due to the hypothesis 
that larger ratios would produce larger amplitudes because of the larger frequency range of 
hearing in canines and that the ratios would not differ from the accepted ratio for testing humans 
to an extreme degree. In addition, it was of utmost importance to balance the amount of test time 
per canine with the priority of conducting testing thoroughly as possible. 
 Brainstem auditory evoked response testing is currently the accepted hearing sensitivity 
assessment by the Orthopedic Foundation for Animals (Sims et al., 2017). Brainstem auditory 
evoked response toneburst results display excellent responses at 4k Hz through 8k Hz and above 





DPOAE responses. The DPOAE SNRs at 2k Hz, 1.4k Hz, and 1k Hz were considered absent, 
which might have been due to the high noise floor; however, it was possible the canine response 
was not as robust at those lower frequencies as it is in humans. At the very low frequencies 
within the audibility frequency range for canines, hearing sensitivity is reduced (Ter Haar et al., 
2002), which might account for the responses for BAER testing and DPOAE testing being 
reduced at the low frequencies. Figure 13, a diagram with the minimum audibility curve for 
humans and canines from Scheifele (2020), depicts the behavioral responses of canines and 
humans to pure-tone stimuli of varying frequencies. The figure illustrates the minimum intensity 
levels canines and humans hear and respond to across the range of frequencies. The greatest 
sensitivity appears to be in the range of 4k to 10k Hz for canines. The greatest sensitivity occurs 
in the range of 1k to 4k Hz for humans. As the frequencies decrease below 2k Hz, canine hearing 
sensitivity is reduced compared to that of humans. The DPOAE results from this study 
corresponded to the minimum audibility curve because the most robust DPOAE responses were 
in the range of greatest hearing sensitivity seen on Figure 13 (Scheifele, 2020) and the responses 
were significantly reduced or absent at 2k Hz; below this point was where hearing sensitivity 








Human and Canine Minimum Audibility Curve (Scheifele, 2020) 
 
Note. Provided courtesy of Dr. Peter Scheifele (2020). 
 
 
Toneburst BAER results and canine minimum audibility curves agreed with behavioral 
studies of canine hearing sensitivity (Ter Haar et al., 2002). The DPOAE results from the current 
study were in agreement with the toneburst BAER results and canine minimum audibility curves, 
which led us to conclude the DPOAE results were in agreement with the behavioral studies and 
BAER test results.  
 All the canines exhibited similar DPOAE frequency responses; 2k Hz and below had 
extremely poor results with amplitudes peaking at 6-8k Hz. This indicated the frequencies of best 
responses for canines were higher than those measured for humans since DPOAE responses for 





responses in the range of 2-4k Hz. The differences in frequency response of DPOAEs for canines 
and humans might relate to the differences in audible hearing range, basilar membrane length, 
and number of turns in the cochlea.  
 The canine DPOAE response amplitudes are much larger than the typical DPOAE 
amplitude in human adults. The amplitudes are more like human infant DPOAE responses. 
Abdala and Keefe (2006) reported as much as a 13 dB difference in DPOAE response amplitude 
for infants when compared to adults. The difference tended to decrease with an increase in age. 
Stamate et al. (2015) reported infant DPOAE responses were larger at high frequencies than 
adult responses. This corresponded to the responses found in the current study as DPOAE 
responses were overall larger in amplitude than adult human responses, especially in the high 
frequencies. The canine DPOAE responses in the current study were more like infant human 
DPOAEs than adult human DPOAEs. 
Study Limitations 
A limitation of this study was the lack of a large sample size that included a variety of 
dog breeds, sizes, genders, and ages. In the current study, no attempt was made to control for size 
(the only limitation being the size of available Mutt Muffs (Safe & Sound Pets, 2021), breed, and 
gender. However, the range of SNRs for the 10 subjects was quite small, especially at 6k Hz and 
8k Hz. Age was limited to a range of 2-8 years old; however further research should be 
conducted if age normative data are to be established. The subjects in the study varied in size, 
age, breed, and gender. However, due to a small sample size, it could prove useful to have 
additional testing to determine if there are variations of responses with respect to those factors. 





be expected that there would be a significant difference in responses or that these results would 
be different for canines with these different factors. 
In addition, it is known that multiple distortion products are produced in mammalian ears 
including those of humans. It has been established that in humans, the distortion product with the 
largest amplitude is 2f1-f2 (Christensen et al., 2015). It is possible that canine ears might respond 
differently to probe frequencies f1 and f2, producing distortion products at other mathematical 
combinations that are larger than those seen in human ears. Further study is needed to determine 
if other distortion products are present in canine ears at levels that vary compared to those of 
humans. 
Prior to using OAEs clinically to aid in diagnosis of hearing status in canines, further 
research needs to be conducted to standardize testing procedures, equipment modifications, and 
software settings that would produce optimal OAEs in canines.  
Test Environment/Use of Mutt Muffs 
The lack of a probe that fits a canine ear canal was an additional limitation. It might be 
beneficial to develop a canine probe if DPOAEs are to be used clinically in veterinary offices as 
a screening tool. Further studies are necessary to determine if there are effective methods to 
reduce ambient noise and/or canine internal noise that could impact DPOAE test results. Mutt 
Muffs (Safe & Sound Pets, 2021) provided adequate ambient noise reduction to collect DPOAE 
responses in the subjects for this study; however, it is still unknown if the Mutt Muffs would 
provide enough ambient noise reduction in a veterinary clinic for DPOAEs to be clinically 
useful. In addition, the Mutt Muffs might have potentially created resonances that influenced the 





conducted to determine if Mutt Muffs impacted DPOAE responses by creating resonances while 
reducing the ambient noise reaching the ear canal.  
Some potential benefits to creating a probe specifically designed for canine ear canals 
include: 
• Less equipment necessary for veterinary clinics to keep on hand to perform hearing 
screenings utilizing DPOAEs. There are multiple sizes of Mutt Muffs (Safe & Sound 
Pets, 2021) to accommodate the large variation of head size in canines so a veterinary 
clinic would need to purchase all available sizes of Mutt Muffs. 
• A better seal might reduce ambient noise more than Mutt Muffs due to the fact that it 
would completely block the ear canal, whereas Mutt Muffs might not always fit or be 
placed correctly. 
• Less user error would occur when the only piece of equipment necessary to place is 
the sealing probe instead of a probe that does not fit and seal correctly in addition to 
the Mutt Muffs. 
• Any potential for a resonance effect with the Mutt Muffs on is eliminated when only 
a specifically designed probe for canine ear canals is used. 
Some benefits of utilizing Mutt Muffs (Safe & Sound Pets, 2021) that might mean a 
probe specifically designed for canine ears is not necessary: 
• The Mutt Muffs reduced ambient noise adequately to collect DPOAEs, meaning the 
effort to develop a special probe might be superfluous. 
• The Mutt Muffs served a purpose in that all 10 subjects of the study were noted to be 
much calmer and more compliant during testing when the Mutt Muffs were secured 





• The Mutt Muffs also prevented the canines from being able to pull the probe out of 
their ear canal by pawing at their ear or shaking their head. 
• The lack of a correctly fitting and sealing probe seemed to be compensated by the use 
of Mutt Muffs. 
The noise floor cutoff was adjusted to 10 dB to allow for consistent data collection. It 
was determined to be unrealistic to have the cutoff noise floor intensity be at 5 dB SPL, 
specifically for the lower frequencies tested (2k Hz and below). The noise floor was consistently 
between 5-15 dB SPL for 2k Hz and below even when the noise floor was below 5 dB SPL for 
the frequencies above 2k Hz. Data collection was continued when the DPOAE responses and the 
noise floor were at or below 10 dB SPL for the frequencies above 2k Hz. Although each canine 
was in the sound booth with the door securely closed, the Mutt Muffs (Safe & Sound Pets, 2021) 
were on and secure, and all ambient noise was reduced or eliminated, there was significant noise 
for the lower frequencies. It is hypothesized that the increase in lower frequency noise might 
have been due to the canine’s internal noise (i.e., breathing, panting, swallowing, licking). 
Extensive efforts were made to keep the canines calm and settled to reduce the noise as much as 
possible. Results from subject 2 (see Appendix B) illustrated the additional noise, in dB SPL, 
that occurred when the canine was consistently panting. Although efforts were made to reduce 
the occurrence of panting during testing, the subject would pant whenever the DPOAE tests were 
being conducted. The canine was approximately 4-years-old at the time of testing, had no risk 
factors for otologic issues, and subjectively responded appropriately to sounds. It should be 
noted that the results from this subject might have been skewed because of the amount of noise 





It was interesting to note that for all subjects tested, there was an inability to record 
DPOAE responses in the frequency range below 2k Hz. This might be due to the canine’s 
internal noise such as breathing, panting, and swallowing. It might also be that canines just do 
not have robust DPOAE responses below 2k Hz because even when the noise floor was low 
(ambient noise level in the empty sound-treated booth measured with sound level meter to be 
40.3  1.5 dBA in the frequency range 31.5 Hz – 8k Hz) and allowed for collection of responses 
at all frequencies tested (i.e., subject 4, f2/f1 ratio: 1.20), there was a consistent lack of responses 
across all 10 subjects for the frequencies below 2k Hz regardless of the f2/f1 ratio tested.  
Recommendations for Clinical Use of Distortion  
Product Otoacoustic Emissions with Canines 
1. Clinical use of DPOAEs on canines at this time should strictly be for hearing 
screening. Distortion product otoacoustic emissions results should not be 
interpreted as hearing test results; if there is a lack of robust responses, then further 
evaluation, such as BAER testing, should be performed to obtain more conclusive 
results of hearing status. This was a great screening tool because it took under five 
minutes total, was non-invasive, could be performed while the canine was awake 
and alert, and could provide ear specific screening results for each canine patient. 
Correlation with audiometric data might be done in the future. 
2. A sound-treated booth was not necessary; however, it would be beneficial if 
available. For the purpose of using DPOAEs in a veterinary clinic, a sound-treated 
booth is likely not available. This does not mean veterinary clinics cannot utilize 
DPOAEs to screen their canine patients. One recommendation would be for 
veterinary clinics to attempt to find a quieter location within their clinic to try to 





3. Distortion product otoacoustic emissions screening might possibly be performed 
without Mutt Muffs (Safe & Sound Pets, 2021); however, without a specially 
designed probe for canine ear canals, a veterinary clinic might have too much 
ambient noise for responses to be collected without Mutt Muffs. Mutt Muffs 
provided that noise reduction and helped to secure the probe in place, both of which 
might be useful in a veterinary clinic setting. 
4. It is recommended to have at least two testers when performing DPOAEs on a 
canine. A set up with two testers is recommended as follows: one person to run the 
DPOAE screening tool (computer, handheld screener) and one person to place the 
probe and then the Mutt Muffs who can restrain or keep the dog calm and compliant 
throughout testing. If this is being performed in a veterinary clinic and the owner is 
present, it is ideal if the owner can sit with the canine to keep them calm and 
compliant. 
5. The results from this study indicated the canine must be relatively quiet, calm, and 
compliant. When one of the canines was panting throughout testing, it was difficult 
to obtain robust responses. The canine should be sitting or lying down, be as still as 
possible, and should be comfortable to avoid panting. Keeping the dog from licking, 
drinking, eating, and making other unnecessary noise is imperative. Some of the 
techniques utilized to help keep the canines quiet were to (a) have the owner there 
and providing calm support for the canine, (b) recommend the canines get some 
exercise prior to the testing (but not immediately before since that would increase 





if needed, (d) provide water, and (e) allow the canine to explore the room for 
approximately 5-10 minutes prior to testing to familiarize them with the space. 
6. The frequency ratios recommended as a result of this study would be ratios in the 
range of 1.18-1.22. Although the f2/f1 ratios that produced the most robust 
responses were 1.18 and 1.20, there was no statistically significant difference 
between any of the f2/f1 ratios utilized in this study. The lack of significance 
between ratios suggested that any of the ratios would be adequate; however, 
because 1.18 and 1.20 did have the most robust responses, it would be ideal to use 
ratios within that range. The ratio 1.22 is typically utilized for DPOAEs in humans 
and due to the robust responses with this ratio, it would be acceptable to use 1.22 at 
this time especially if that aided in ease of use. 
7. The results from the study suggested a certain range of frequencies should be 
focused on to determine a pass/fail for screening purposes. Due to the consistent 
lack of responses below 2k Hz, it is recommended the screening guidelines for a 
pass/fail would focus on frequencies at and above 2k Hz. This would especially be 
true if the screening was being performed in a clinic environment where there 
would potentially be greater environmental noise, further reducing results below 2k 
Hz even more. The screening could include frequencies below 2k Hz; however, the 
pass/fail criteria are not recommended to be based on those frequencies as it would 
likely cause a high percentage of canines to have false positive results. This means 
DPOAE instrumentation designed for use with humans should be modified to avoid 





8. Future research is a necessity if DPOAEs are to become a clinical screening tool for 
canines’ hearing status. Studies of a greater scale and controlled for age, size, breed, 
and gender would provide greater insight into the expected results for DPOAEs in 
canines with normal hearing sensitivity. If this tool is to be used clinically, research 
would need to be conducted to provide normative values for all canines. 
Additionally, it would prove useful to create canine probe tips and an earmuff 
system to secure and reduce ambient noise in the environment that could be used in 
clinics. Standardizing test procedures and settings on software that would produce 
optimal DPOAE results is also recommended. 
Conclusions 
Distortion product otoacoustic emissions were successfully elicited on all 10 canine 
subjects in the study with Mutt Muffs (Safe & Sound Pets, 2021) on in a sound-treated booth. 
The DPOAE responses were consistent across the different ratios tested for each canine. From 
the results of the study, it could be concluded that DPOAEs could be elicited from the canine ear. 
If DPOAEs are to be used clinically as a screening tool in veterinary clinics, they must be 
a relatively simple, quick, and non-invasive procedure. Some considerations regarding the 
clinical usefulness of DPOAEs are that veterinary offices are spaces with greater ambient noise 
than a sound booth, the canine must be relatively calm and settled, and the use of Mutt Muffs 
(Safe & Sound Pets, 2021) might be necessary to help reduce the ambient noise. Even with the 
extensive efforts of ambient noise reduction in the study, there were typically high levels of noise 
for the lower frequencies. This was hypothesized to be due to internal noise such as the canine’s 
breathing, panting, swallowing, licking, etc. When adding the internal noise to the ambient noise 





The purpose of this study was to determine what stimulus frequency ratios would 
produce the most robust OAEs in canines to support future clinical use of OAEs to aid in 
diagnosis of hearing status in canines. The results from the study indicated f2/f1 ratios between 
1.18 and 1.28 did not produce significantly different DPOAE elicitations of the 2f1-f2 emission 
in canines and the amplitude patterns of the distortion products did not change significantly with 
changes in the f2/f1 ratio for ratios between 1.18 and 1.28.  
Based on results from the study, it was concluded the typical canine DPOAE response 
was 2k Hz and above. Lack of DPOAE responses below 2k Hz regardless of the noise floor 
levels, low ambient noise, and level of canine compliance and degree of quietness suggested the 
typical DPOAE response was best at 2k Hz and above. In general, the canine DPOAE responses 
were robust enough that the f2/f1 ratio did not seem to significantly impact the overall 
amplitudes. Due to the lack of a probe specifically designed for canine ears, use of Mutt Muffs 
(Safe & Sound Pets, 2021) or a similar device is recommended; however, further research is 
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DISTORTION PRODUCT OTOACOUSTIC EMISSIONS  
LINE GRAPH REPRESENTATIONS  
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MEAN SIGNAL-TO-NOISE RATIOS FOR EACH RATIO  






Ratio Freq M (dB) SD N 
1.18 1K 0.0000 0.00000 10 
1.4K 0.3800 1.16695 10 
2K 1.8300 3.78713 10 
2.8K 9.5200 8.75681 10 
4K 17.4900 8.39860 10 
6K 25.7300 7.92886 10 
8K 22.0800 10.13737 10 
1.20 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 2.7800 4.74477 10 
2.8K 11.0700 8.96971 10 
4K 18.3900 13.49728 10 
6K 26.5800 10.29539 10 
8K 22.6900 9.85128 10 
1.21 1K 0.4000 1.26491 10 
1.4K 0.0000 0.0000 10 
2K 2.2000 3.44513 10 
2.8K 8.4500 8.76537 10 
4K 15.0200 10.67310 10 
6K 23.8100 12.83445 10 
8K 19.6600 12.15376 10 
1.22 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 1.5200 4.40121 10 
2.8K 6.5700 8.49929 10 
4K 13.0500 10.53252 10 
6K 23.2600 9.56907 10 
8K 22.4400 9.54512 10 
1.23 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 0.2400 0.75895 10 











Ratio Freq M (dB) SD N 
1.23 4K 9.9300 7.40646 10 
6K 20.1500 6.12867 10 
8K 17.4200 9.78511 10 
1.24 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 1.3500 2.36890 10 
2.8K 6.5900 9.71922 10 
4K 14.7600 11.15250 10 
6K 22.8800 11.98998 10 
8K 19.1700 9.83114 10 
1.25 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 0.9600 2.17675 10 
2.8K 6.1000 6.72524 10 
4K 12.8800 9.15312 10 
6K 22.9500 10.01435 10 
8K 20.2200 10.33148 10 
1.26 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 1.2600 2.01119 10 
2.8K 6.0900 6.97686 10 
4K 12.6900 7.82453 10 
6K 21.6400 11.73894 10 
8K 18.9100 11.44799 10 
1.28 1K 0.0000 0.0000 10 
1.4K 0.0000 0.0000 10 
2K 0.6900 2.11263 10 
2.8K 7.0500 8.35387 10 
4K 11.9400 11.46862 10 
6K 20.5100 11.64135 10 
8K 18.3000 11.69197 10 
 
 
